跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 108 条关于
“PRX3”
全部
108
临床试验
57
药物
42
机构
0
资讯
9
2个月前
New Drug RSO-021 Shows Promise in Mesothelioma Trial by Targeting Cancer's Energy System
去年
Singapore's PRL3-zumab Shows Promise in Phase II Trial for Treatment-Resistant Solid Tumors
去年
Singapore-Developed Cancer Drug PRL3-zumab Shows Promise for Treating Vision Loss in AMD and Diabetic Retinopathy
去年
Protalix's PRX-115 Demonstrates Promising Results in Phase I Gout Trial
去年
Protalix's PRX-115 Shows Promise in Phase I Gout Trial with Extended Dosing Potential
去年
Protalix Bio Presents Positive Phase 1 Data for PRX-115 in Uncontrolled Gout
去年
Protalix BioTherapeutics Announces Positive Phase 1 Results for PRX-115 in Uncontrolled Gout
去年
Protalix's PRX-115 Demonstrates Dose-Dependent Urate-Lowering in Phase 1 Gout Study
去年
Protalix Advances PRX-115 Gout Treatment to Phase II Following Promising Early Results and Strong Q1 Revenue